Tobam Sells 4,088 Shares of Cardinal Health, Inc. $CAH

Tobam decreased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 45.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,845 shares of the company’s stock after selling 4,088 shares during the quarter. Tobam’s holdings in Cardinal Health were worth $814,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Counterpoint Mutual Funds LLC bought a new position in shares of Cardinal Health during the 2nd quarter valued at about $1,911,000. KLP Kapitalforvaltning AS raised its holdings in Cardinal Health by 4.0% during the 2nd quarter. KLP Kapitalforvaltning AS now owns 114,198 shares of the company’s stock worth $19,185,000 after buying an additional 4,400 shares during the period. Czech National Bank lifted its stake in Cardinal Health by 5.1% in the second quarter. Czech National Bank now owns 58,341 shares of the company’s stock valued at $9,801,000 after buying an additional 2,857 shares in the last quarter. Zurich Insurance Group Ltd FI lifted its stake in Cardinal Health by 4,935.9% in the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock valued at $130,434,000 after buying an additional 927,950 shares in the last quarter. Finally, Accurate Wealth Management LLC boosted its holdings in shares of Cardinal Health by 92.8% in the second quarter. Accurate Wealth Management LLC now owns 3,627 shares of the company’s stock valued at $588,000 after buying an additional 1,746 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Down 0.3%

CAH opened at $204.77 on Wednesday. Cardinal Health, Inc. has a 12-month low of $114.60 and a 12-month high of $207.47. The business has a 50 day moving average of $162.25 and a 200-day moving average of $157.83. The stock has a market cap of $48.65 billion, a price-to-earnings ratio of 31.75, a PEG ratio of 1.39 and a beta of 0.72.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. During the same period in the previous year, the firm earned $1.88 EPS. The firm’s revenue was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be given a $0.5107 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio is presently 30.77%.

Insider Activity at Cardinal Health

In other Cardinal Health news, insider Ola M. Snow sold 28,151 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total value of $4,192,809.94. Following the transaction, the insider directly owned 15,431 shares of the company’s stock, valued at $2,298,293.14. This represents a 64.59% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jessica L. Mayer sold 38,078 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the sale, the insider owned 48,457 shares of the company’s stock, valued at approximately $7,211,370.74. This represents a 44.00% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 271,676 shares of company stock worth $40,489,525 in the last quarter. 0.12% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

CAH has been the topic of a number of research analyst reports. Robert W. Baird set a $232.00 price objective on shares of Cardinal Health in a report on Friday, October 31st. Argus boosted their target price on Cardinal Health from $189.00 to $211.00 and gave the company a “buy” rating in a research note on Tuesday, November 4th. Mizuho lifted their price target on shares of Cardinal Health from $170.00 to $210.00 and gave the company an “outperform” rating in a research note on Monday, November 3rd. Evercore ISI increased their price objective on shares of Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a research note on Friday, October 31st. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, October 8th. Twelve equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $205.00.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.